East Meets West in the Search for Alzheimer's Therapeutics - Novel Dimeric Inhibitors from Tacrine and Huperzine A

E-ISSN： 1875-5828|4|4|386-396

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.4, Iss.4, 2007-09, pp. : 386-396

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alzheimer's Therapeutics

By Massa S.M. Xie Y. Longo F.M.

Journal of Molecular Neuroscience, Vol. 19, Iss. 1-2, 2002-10 ,pp. : 107-112

Humana Press, Inc

Access to resources Recommend Favorite

Nucleic Acid Aptamers as Novel Class of Therapeutics to Mitigate Alzheimer's Disease Pathology

Current Alzheimer Research, Vol. 10, Iss. 4, 2013-05 ,pp. : 442-448

Bentham Science Publishers

Access to resources Recommend Favorite

Tau Therapeutics for Alzheimer’s Disease : The Promise and the Challenges

By Gold Michael

Journal of Molecular Neuroscience, Vol. 19, Iss. 3, 2002-12 ,pp. : 329-334

Humana Press, Inc

Access to resources Recommend Favorite

Signal Transduction Therapeutics: Relevance for Alzheimer's Disease

By da Cruz e Silva Odete A. B. Fardilha Margarida Henriques Ana Gabriela Rebelo Sandra Vieira Sandra da Cruz e Silva Edgar F.

Journal of Molecular Neuroscience, Vol. 23, Iss. 1-2, 2004-04 ,pp. : 123-142

Humana Press, Inc

Access to resources Recommend Favorite

Apolipoprotein E as a target for developing new therapeutics for Alzheimer’s disease based on studies from protein, RNA, and regulatory region of the gene

By Lahiri Debomoy

Journal of Molecular Neuroscience, Vol. 23, Iss. 3, 2004-10 ,pp. : 225-233

Humana Press, Inc

Access to resources Recommend Favorite